Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 80102512906

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80102512906 and manufactured by ACON BIOTECH (HANGZHOU) CO.,LTD.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until Nov 21, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80102512906
2 Related Devices
Registration Details
ANVISA Registration Number: 80102512906
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Família Teste rápido de antígeno do SARS-CoV-2 (autoteste)
Risk Class III

Registration Details

80102512906

25351133564202292

04718143000194

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Nov 21, 2022

21/11/2032

09/18/2025 19:00:01

Família Teste rápido de antígeno do SARS-CoV-2 (autoteste)
Risk Class III

Registration Details

80102512906

25351133564202292

04718143000194

Dates and Status

Nov 21, 2022

21/11/2032

09/18/2025 19:00:01